| Financial Year |
March 31 2023 |
| Monetary Funds |
708,007,957.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,087,323.38 |
| Accounts Receivable |
1,486,070,505.26 |
| Advances to Suppliers |
209,753,648.95 |
| Other Receivables |
44,579,019.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,192,092.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
398,380,732.89 |
| Total Current Assets |
2,943,071,280.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,137,939,074.40 |
| Investment Properties |
-- |
| Fixed Assetes |
33,974,503,037.09 |
| Under-construction Projects |
3,547,470,913.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
668,846,705.02 |
| R&D expenses |
-- |
| Goodwill |
288,640,760.26 |
| Long-Term Deferred and Prepaid Expenses |
227,176.41 |
| Deferred Income Tax Assets |
24,077,857.16 |
| Other Non-Current Assets |
1,274,178,533.67 |
| Sub-Total of Non-Current Assets |
41,699,550,781.38 |
| Total Assets |
44,642,622,061.89 |
| Short-Term Loans |
5,088,355,477.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,603,530,649.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,178,558.26 |
| Taxes Payable |
322,110,410.62 |
| Interest Payable |
-- |
| Dividend Payable |
8,201,296.29 |
| Other payables |
282,950,701.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,245,371,540.78 |
| Other Current Liabilities |
1,031,971.67 |
| Sub-Total of Current Liabilities |
10,577,280,725.09 |
| Long-term Loans |
10,131,416,293.25 |
| Bonds Payable |
999,478,380.10 |
| Long-Term Accounts Payable |
49,690,896.35 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,095,442.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,713,493,708.73 |
| Total Liabilities |
22,290,774,433.82 |
| Paid-In Capital(Or Share Stock) |
7,882,377,802.00 |
| Capital Surplus |
979,958,041.96 |
| Surplus Reserve |
2,294,473,413.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,881,453,679.43 |
| Minority Stockholder's Interest |
3,121,653,604.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,230,194,023.30 |
| Owner's Equity（Stockholder's Equity） |
22,351,847,628.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
44,642,622,061.89 |
